A ortic valve calcification is the leading cause of aortic valve stenosis, which is a progressive disease that results in heart failure, angina, syncope, and death. The prevalence of aortic valve stenosis is ≈0.2% among adults between the ages of 50 and 59 years but increases to 2.8% in adults ≥75 years of age. Aortic valve stenosis does not cause symptoms for long periods of time, but the rate of death is >50% at 2 years when patients become symptomatic unless aortic valve replacement is performed. 1, 2 It is now recognized that aortic valve calcification is not a passive process of calcium deposition that occurs with advanced age, but, instead, it is an active process that involves valve, circulating, and bone marrow-derived cells along with biochemical and mechanical factors. 3, 4 See accompanying editorial on page 387
Wnts are lipid-modified glycosylated proteins encoded by 19 genes. They bind to extracellular Frizzled receptors leading to activation of multiple signaling pathways that are diverted into the main branches: the classical or canonical β-catenindependent pathway and the β-catenin-independent pathways, collectively known as the noncanonical pathways. [5] [6] [7] [8] Wnt signaling pathways have multiple functions in heart valves in the regulation of endothelial-to-mesenchymal transition and cell proliferation during the initial stages of endocardial cushion and heart valve formation. 9, 10 There is strong evidence suggesting the involvement of canonical Wnt signaling cascade in valve calcification. 11 Caira et al 12 found that LRP5 (lowdensity lipoprotein receptor-related protein 5)/Wnt3 signaling markers were highly expressed in human calcified aortic valves. Despite the fact that there is evidence implicating Wnt signaling in osteogenic differentiation and development, little is known about the role of noncanonical Wnt ligands, such as WNT5a, WNT5b, and WNT11, in valvular calcification. The prototypical noncanonical ligand WNT5a has been implicated in the development of atherosclerotic plaques, such as in smooth muscle cells and macrophage infiltration. [13] [14] [15] Other recent work supporting the involvement of WNT5a, coreceptor LRP6, and canonical Wnt signaling in vascular calcification merits the investigation of other noncanonical Wnt ligands and their roles in stenotic valve disease. [16] [17] [18] In this study, we hypothesized that the noncanonical Wnt ligands WNT5a, WNT5b, and WNT11 are upregulated in stenotic aortic valves and may contribute to the pathogenesis of the disease. We, therefore, examined cellular and total protein expression of WNT5a, WNT5b, and WNT11 in aortic valves by immunohistochemistry and Western blotting. We also examined the relative mRNA expression of WNT11, WNT5a, and WNT5b in calcified aortic valves. We further isolated human aortic valve interstitial cells (HAVICs) from noncalcified and calcified aortic valves and assessed the effect of WNT5a, WNT5b, and WNT11 on cell mineralization using Alizarin Red S staining and Raman spectroscopy and determined gene expression of osteogenic mediators.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Expression of Noncanonical Wnt mRNAs and Protein in Human Aortic Valves and HAVICs
There were significantly higher expressions of WNT5a, WNT5b, and WNT11 mRNAs in calcified aortic valves compared with normal valves ( Figure 1A ; P<0.05).
The mRNA expression of WNT5b was significantly higher in calcified bicuspid aortic valves compared with calcified tricuspid aortic valves ( Figure 1B ; P<0.05). The mRNA expression of WNT5a and WNT11 were higher in calcified bicuspid valves compared with calcified tricuspid aortic valves, but it did not reach statistical significance ( Figure 1B) .
Western blot results showed robust WNT5b expression in cultured HAVICs isolated from stenotic aortic valves and stenotic aortic valve tissues and no detectable expression in normal dermal fibroblast cells. Although there is a WNT5b signal at the predicted size of 37 kDa, there is also strong signal at 75 kDa, suggesting the occurrence of post-translational modifications or potential dimerization of the Wnt ligands ( Figure 1C ). Cell lysate from HEK293 cells revealed a similar expression pattern to what was observed in human aortic valve tissue (data not shown). Both aortic valve tissues and cultured HAVICs show abundant WNT11 protein expression ( Figure 1D ).
Immunohistochemical Analysis of WNT5a and WNT5b
There was little immunoreactivity for WNT5b in histologically normal valves. Specifically, low immunoreactivity was evident in valvular interstitial cells (VICs) and endothelial cells on both aortic and ventricular sides of the leaflet (Figure 2A ). WNT5b immunostaining was strongest in severely calcified valves, with immunoreactivity in VICs on both the aortic and ventricular sides of valve leaflet and in areas of calcific stippling and large developed calcification nodes ( Figure 2B ). Strong WNT5b immunostaining was also evident in macrophages in areas of inflammation ( Figure 2B ) and in region of lipid ( Figure 2C ). WNT5b immunostaining was strong in severely remodeled valves. In these tissues, WNT5b immunoreactivity was abundantly seen in VICs in areas of extensive fibrosis ( Figure 2D and 2E) and valve thickening ( Figure 3A and 3B). Although WNT5b immunostaining was found in quiescent VICs, immunoreactivity was stronger in activated VICs and in osteoblasts ( Figure 2F ) and colocalized with osteopontin ( Figure 2G ), β-catenin ( Figure 2J) Little to no apparent WNT5a immunoreactivity was seen in normal valves or normal segments of diseased valves. Focal strong WNT5a immunoreactivity was seen in inflammatory cells and some activated myointimal cells within and surrounding calcified foci. Negative control sections showed no staining ( Figure 3H ). 
Immunohistochemical Analysis of WNT11
On average, WNT11 immunoreactivity was lowest in human aortic valves with no calcification. Specifically, there was low WNT11 immunoreactivity in endothelial cells and VICs on both sides of valve leaflets with slightly stronger staining on the ventricular side of the leaflets ( Figure 3C ). WNT11 immunostaining was strongest in severely calcified aortic valves particularly in areas of calcific stippling and large developed calcification nodes; in tissues with severe remodeling, WNT11 immunostaining was strong in VICs resembling myofibroblasts and microvessels ( Figure 3D ). WNT11 immunostaining was also noted in monocytes and macrophages in areas of inflammation and colocalized with CD68 staining ( Figure 3F ). Negative control sections did not exhibit any immunostaining ( Figure 3H ).
Semiquantitative analysis of WNT11 revealed that immunostaining intensity was lowest in histologically normal valves (1.43±0.23). One-way ANOVA Kruskal-Wallis test showed that WNT11 immunostaining intensity in normal aortic and mitral valves was not significantly different from WNT11 immunostaining in normal segments of diseased valves ( 
Effects of Noncanonic Wnts on HAVICs Proliferation, Apoptosis, and Alkaline Phosphatase Activity
After 48-hour treatment with rhWNTs in DMEM, only rhWNT5b significantly reduced cell proliferation ( Figure 4A ). When cells were cultured in osteogenic medium (OSM), both rhWNT5a (at 200 ng/mL) and rhWNT5b significantly reduced cell proliferation ( Figure 4B ). After 3-week incubation, all 3 Wnts significantly decreased cell proliferation of HAVICs ( Figure 4C ). Incubation of HAVICs with rhWNT5a, rhWNT5b, and rhWNT11 for 4 hours, and 24 hours in OSM caused a significant increase in cell apoptosis assayed by annexin V/eFluor 780 staining ( Figure 5 ). The same result was also assessed by caspase-3/7 activity on HAVICs treated for 10 days with rhWNTs using CellEvent Caspase-3/7 Green Detection Reagent ( Figure I in the online-only Data Supplement).
Cultured HAVICs have been demonstrated to undergo in vitro calcification via a process dependent, in part, on the upregulation of alkaline phosphatase (ALP) activity. 19 Although HAVICs from noncalcified aortic valves show low ALP activity, all 7 HAVICs lines generated from stenotic aortic valve leaflets show significant amount of ALP activity (3-6 U/mg). Treatment of HAVICs collected from noncalcified valves with recombinant human Wnts showed no effect on ALP activity after 48-hour incubation in either media.
Prolonged Incubation of Noncanonic WNTs Induce Significant Calcification of HAVICs and Osteogenic-Related Gene Expression
All 3 noncanonical Wnts resulted in significant increases of calcium deposition and formation of calcified nodules in HAVICs isolated from noncalcified human aortic valves after 3-week incubation in OSM (P<0.05; Figure 6A ). Combined incubation of rhWNT5a and rhWNT11, but not rhWNT5b and Raman spectra collected on lysates from HAVICs treated with above rhWNTs showed an intense peak located at 960 cm− 1 ( Figure 6B , spectra b through d). This peak corresponds to the ν1 vibration of the phosphate group and is indicative of the formation of hydroxyapatite on these samples, as shown by the comparison with spectra of reference hydroxyapatite, bone, and enamel samples ( Figure 6D , spectra b through d).
No phosphate peak was found in HAVICs without Wnt treatment ( Figure 6B, spectrum a) . The same type of hydroxyapatite deposit was found in HAVICs from calcified heart valves ( Figure 6D, spectrum a) . By integrating the area of the ν1 phosphate peak and dividing this value by the area of the peak at 1440 cm −1 , which is relative to the stretching of CH2/CH3 groups, we estimated the amount of inorganic deposits relative to the amount of organic material found in each sample. Largely increased hydroxyapatite deposition were found in HAVICs treated with rhWNTs; a significant increase in hydroxyapatite deposition was found in rhWNT5a-and rhWNT11-treated HAVICs compared with nontreated HAVICs; cells treated with rhWNT11 showed even more abundant hydroxyapatite deposits than calcified heart valves ( Figure 6C) .
By measuring the full width at half maximum of the ν 1 phosphate peak, it is possible to estimate the degree of crystallinity of the hydroxyapatite deposits. Wider peak indicates a less crystalline material, whereas sharper peak shows a higher crystallinity. 20 We compared the full width at half maximum measured on HAVICs treated with rhWNTs (3 weeks)to that measured on calcified heart valves ( Figure 6F) ; no statistically significant differences were found, indicating the same degree of crystallinity for these deposits (full width at half maximum between 22 and 24 on all samples). Lower full width at half maximum were found not only on synthetic hydroxyapatite (5.3±0.1) but also on natural samples such as bone (18.1±0.2) and enamel (11.7±0.3) (Figure 6F ), which indicates that less crystalline hydroxyapatite is deposited in ectopic calcification in stenotic aortic valves than in physiological hard tissues.
Incubation of HAVICs isolated from noncalcified aortic valves with 200 ng/mL recombinant Wnts in DMEM showed that rhWNT5b increased OPN, MYH11, CNN1, and JAG2 (Table III in the online-only Data Supplement). rhWNT11 increased the expression of OPN, BGLAP, RUNX2, and TGFβ. When HAVICs from noncalcified valves were cultured in OSM, rhWNT5b increased expression of MYH11, αSMA, CNN1, SP7, and JAG2 (Table IV in the online-only Data Supplement). Other rhWNTs showed no significant effects. HAVICs isolated from calcified aortic valves also showed a significant change in the expression of osteogenic genes when treated with 200 ng/mL recombinant noncanonical Wnts. For example, stimulation with rhWNT5a resulted in upregulation of BMP2 (bone morphogenetic protein 2), collagen IIIA1, and PPARγ; rhWnt5b stimulation led to upregulation of BMP2, collagen IIIA1, and αSMA and downregulation of collagen IA1 (>90%) and SOX9 (>80%). Treatment with rhWnt11 significantly increased expression of BMP2, collagen IA1, αSMA, and PPARγ (Table V in the online-only Data Supplement).
Effects of Noncanonical Wnts on PhosphoMitogen-Activated Protein Kinases and Effects of Pathway Inhibitors on Calcification
When noncalcified HAVICs were treated with 100 ng/mL of rhWNTs, phosphorylation of c-Jun N-terminal kinase 1/2/3 (JNK1/2/3), serine-threonine protein kinase 1 (Akt1), and mitogen-activated protein kinase-38β (MAPK38) were significantly increased, and rhWNT5a showed the strongest increase ( Figure 
Discussion
Aortic valve calcification is an active process that involves mechanical and biochemical factors leading to valve degeneration and stenosis. The critical features of aortic valve calcification that involve VIC activation to osteoblast and bone formation lead to the growing interest in exploring the role of bone metabolism pathways in the aortic valve calcification such as Wnt pathways.
3,4,21 Involvement of canonical Wnt signaling in human valve calcification has been previously reported 11, 12, 22 ; however, this study implicates noncanonical Wnt ligands WNT5b and WNT11 in the pathogenesis of aortic valve calcification. The mRNA expression of WNT5a, WNT5b, and WNT11 was higher in calcified valves compared with normal valves. Interestingly, we found significantly higher mRNA expression of WNT5b in calcified bicuspid aortic valves compared with calcified tricuspid aortic valves. We also demonstrated that HAVICs from calcified aortic valves express abundant levels of WNT5b and WNT11 proteins via Western blotting, whereas dermal fibroblasts showed minimal to no expression of these ligands. Moreover, in noncalcified HAVICs, all 3 noncanonical Wnts were found to have strong apoptotic effect and induced calcification of these cells. Taken together, these findings suggest a possible role for noncanonical Wnt pathway in the pathogenesis of aortic valve calcification.
The Wnt-Frizzled system, involving 19 Wnt ligands and 10 Frizzleds, plays key roles in the development and function of multiple organs including the cardiovascular system. 22 Wnt signaling is also thought to be required for different aspects of cardiac and vascular development, including myocardial specification, cardiac morphogenesis, cardiac valve formation, and endothelial and vascular smooth muscle cell proliferation. 23 Furthermore, Wnt modulators were found to be involved in several cardiac diseases including myocardial infarction, arrhythmia, and heart failure. [24] [25] [26] Several in vitro and animal studies demonstrated the role of Wnt/β-catenin signaling in inducing osteogenic signaling and the development of aortic valve disease.
11,27-29
Caira et al 12 demonstrated an active endochondral bone formation mechanism in the development of heart valve disease associated with high expression of Wnt3a (important canonical Wnt factors) and coreceptors LRP5/6 in human calcified aortic valves. Askevold et al 30 found increased serum level and tissue expression of Wnt modulators (sFRP3, WIF-1, and DKK-1) in symptomatic aortic valve stenosis. In this study, we found high mRNA expression of WNT5a, WNT5b, and WNT11 in calcified aortic valves compared with normal aortic valves. Our histological studies showed that both WNT5b and WNT11 have high immunostaining in areas of active calcification in calcified valves and in activated osteoblast-like VICs. WNT5b immunostaining was also high in fibrous regions surrounding active calcification in diseased valves. The presence of these noncanonical Wnts in areas of increased matrix deposition, inflammation, and calcification suggests possible autocrine and paracrine roles in aortic valve disease. In particular, the strong immunostaining of WNT5b and WNT11 in macrophages in inflammatory regions of diseased valves suggests that inflammatory cells provide a potential mechanism for the model proposed by Aikawa et al where atherosclerotic plaque inflammation is the trigger for osteogenesis and calcification.
The aortic valve is an avascular structure that is made up of VICs arranged in 3 layers. VICs maintain the integrity of valve tissue by secreting extracellular matrix, including collagen, elastin, and glycosaminoglycans, that provide strength and elasticity to the valve. 31 In situ transition of VICs to osteoblast-like cells is an important mechanism implicated in the pathogenesis of aortic valve calcification. The activated VICs are responsive to osteogenic mediators such as BMPs that stimulate osteoblasts to initiate skeletal bone formation. 32, 33 In this study, we generated primary cultures of VICs from calcified human aortic valves. This allows for more targeted studies of the specific functional roles of these cells in heart disease. Our Western blot findings in isolated HAVICs provide further evidence for the presence of Wnt protein formation. Although there is evidence supporting the role of WNT5b as a regulator of osteoblastic lineage allocation, 34, 35 its exact role in this process is not fully understood. Here, we show profound osteogenic effect of Wnts on HAVICs, which was further confirmed by a spectroscopic analysis of the deposits. On incubation in OSM for 21 days, only HAVICs treated with Wnts showed the presence of hydroxyapatite deposits, whereas nontreated HAVICs did not significantly mineralize. The amount of hydroxyapatite deposits was lower than that found in calcified heart valves for cells treated with WNT5a and higher for those treated with WNT11. The crystallinity of the hydroxyapatite deposits found in Wnttreated AVICs was comparable to that found in calcified heart valves. This suggests that the deposits formed in the presence of Wnt are actually similar to those found in calcified heart valves, thus confirming the importance of Wnts in heart valve mineralization.
Normal human aortic valves contain few macrophages, whereas calcified human aortic valves have significant infiltration of macrophages and leukocytes. This suggests that aortic valve disease, similar to atherosclerosis, can be considered as an active inflammatory process, and it has been suggested that macrophage and inflammatory cell infiltration is involved in the early development of aortic valve disease. 36, 37 Both WNT5b and WNT11 were found to have significantly elevated immunostaining in monocytes and macrophages in calcified valves. Several studies highlight that some inflammatory cytokines may induce ectopic calcification of human adipose tissue-derived mesenchymal stem cells via activation of noncanonical Wnt pathways. 38 In addition, inflammatory cytokines can promote the production of proapoptotic ligands such as transforming growth factor-β1 and tumor necrosis factor-related apoptosis-inducing ligand that have been detected in human calcified aortic valves. 39 Wnt proteins are important in organogenesis and tissue hemostasis, and several studies highlight their role in apoptosis. 40, 41 In this study, all 3 Wnts had strong apoptotic effect on noncalcified HAVICs that may suggest possible mechanism of valve degeneration and calcification. This is further supported by the WNT11-increased expression of transforming growth factor-β and by the findings that the ERK1/2 inhibitor PD184352, that is known to increase cell apoptosis, significantly increased HAVICs calcification. Interestingly, although all noncanonical Wnts studied here significantly increased HAVICs calcification, none had significant effect on ALP activity. This suggests that noncanonical Wnts induce calcification independent of ALP activity via mechanisms similar to what has been reported in vascular calcification pathogenesis, 42 a pathway that may involve apoptosis.
Bicuspid aortic valve is the most common congenital cardiac abnormality with an estimated prevalence of 1% to 2%. It is associated with incidence of aortic valve calcification, aortic aneurysm formation, and aortic dissection. 43 The exact pathogenesis of the formation of BAV is not yet fully understood. It is thought there is a genetic component, especially given the association between BAV and other congenital abnormalities such as coarctation of the aorta. 44 Mutations in NOTCH1 gene, a transmembrane receptor that has a role in determining cell outcome in organogenesis, were noted in 2 families with BAV and also in sporadic cases. 45, 46 It was found that Notch1 normally represses the gene encoding BMP2 in murine aortic valves in vivo and in aortic VICs in vitro. 47 Several studies highlight the counteractive interaction between NOTCH and Wnt signaling in heart development and diseases. 48, 49 In this study, we found a significant increase of Wnt5b in bicuspid compared with tricuspid valves, and this may suggest its involvement in the development and pathogenesis of this disease. Moreover, all noncanonical Wnts increased expression of BMP2 in calcified HAVICs. There was also increased phosphorylation of GSK3β and MAPK38β, both of which have previously been shown to be involved in Wnt activation and osteogenic differentiation. These findings were further supported by our observation of significant decrease in HAVICs calcification in response to treatment with the GSK3β and MAPK38 inhibitors.
In addition to the evidence suggesting a role for WNT5b and WNT11 signaling in the pathogenesis of aortic valve calcification, both ligands demonstrated interesting significant correlations with various clinical parameters. It is a general rule that the pressure gradient across a valve is inversely related to the area of the orifice. 50 Both WNT5b and WNT11 immunostaining demonstrated significant negative correlations with the area of the orifice and significant positive correlations with aortic jet velocity, Pmax, and Pmean. This suggests direct associations between WNT5b and WNT11 protein expression and aortic valve stenosis. Additionally, it has been previously demonstrated in osteoblasts that mechanical stimulation causes increased Wnt production, which then affects the functionality of those osteoblasts. 51 This raises the possibility that it is actually the increased pressure across a valve that is stimulating increased Wnt production and that this increased Wnt signaling then mediates pathological calcium deposition through activation of VICs. In this study, we found that WNT5b has a positive correlation with Parsonnet score. This score was developed as a preoperative risk-assessment score for cardiac surgeries. 52 By taking into account 37 factors, such as age, sex, congestive heart failure, hypertension, diabetes mellitus and morbid obesity, among others, the Parsonnet score has been successfully used preoperatively to predict surgical outcomes. The fact that WNT5b positively correlates with Parsonnet score suggests that WNT5b may be used as a prognostic marker for valve replacement operations.
Given our findings that rhWNT5a, rhWNT5b, and rhWNT11 all induce expression of osteopontin, a key regulator of orthotopic and heterotropic mineralization, future studies warrant the investigation of the relationship between noncanonical Wnt signaling and osteopontin in vascular and valvular mineralization.
There is increasing evidence that valve extracellular matrix, 50% of which consists of collagen by dry weight, plays a role in aortic valve calcification, specifically via its interaction with VICs. 53 Our findings demonstrate differential roles of Wnt signals on collagen IIIA1 and IA1, with rhWNT5a and rhWNT5b contributing to the upregulation of collagen IIIA1; meanwhile, rhWNT5b decreased the expression of collagen IA1, and rhWNT11 increased its expression. This may be explained in part by work by Eriksen et al 54 demonstrating that turnover of collagen type I is significantly increased in aortic stenosis, particularly around calcified nodules. Their findings also demonstrate slight upregulation of type III collagen in calcified valves. Together, this suggests that Wnt signaling could be contributing to aortic valve calcification by mediating interactions between VICs and extracellular matrix.
In summary, we demonstrate here increased expression of 3 important members of the Wnt family, WNT5a, WNT5b, and WNT11, in the valves of patients with aortic valve stenosis, and the association of this increase with clinical and pathological characteristics of the disease. Given that there is no previous work on the involvement of noncanonical Wnt pathway in aortic valve calcification, our findings make an important contribution to developing a better understanding of this pathological process. Because mTOR and JNK inhibition did not diminish calcium deposition, noncanonical Wnt signaling relays promoting VIC mineralization have yet to be fully elucidated. These findings also illustrate the importance of future studies in determining functional roles of Wnt signaling molecules in the osteogenic differentiation of valve interstitial cells and aortic valve calcification.
Perspectives
Even in the absence of valvular stenosis, aortic valve calcification is associated with an increased risk of cardiovascular events and mortality from cardiovascular causes, which is alarming given that there are no proven treatments to avoid or slow its development. Interfering with the Wnt pathway may provide a novel way to treat the disease.
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